Oncology Focus Areas

Our other therapy areas

Immunology Focus Areas
Neuroscience Focus Areas
Contact Us

Report Adverse Event
Contact us

Register
Login

{%buzitemName%}

{%buzbrandMenuItems%}

{%bitemName%} {%barrowSpan%}

{%bsubBrandMenuItems%}

{%sbitemName%} {%sbarrowSpan%}

{%sbproductMenuItems%}

{%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}

{%pselfProduct%}

{%mNavitemName%}

{%lSlanguageSelectorLabel%}

{%lSactiveLanguage%}

{%lScountries%}

{%allMenuItem%}

{%cScountryInfo%}

{%cSlanguages%}

This website is for UK Healthcare Professionals only

Oncology Focus Areas

Haematology

UK-VNCCLL-260096. Date of preparation: April 2026

Our therapy areas

Immunology

Oncology

Neuroscience

Additional info

Privacy Notice

Terms of Use

Contact us

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie on GBPV@abbvie.com

This website is for UK Healthcare Professionals only

UK-ABBV-250400. Date of preparation December 2025. This website has been developed and funded by AbbVie Ltd.

© 2023 AbbVie Ltd. All rights reserved. Registered Number: 08004972 England.

Leaving Site

You are now leaving the AbbVie Pro Portal and being re-directed to an external website which is not under the control of AbbVie. AbbVie is not responsible for content of any such site or any further links from such site.

Do you wish to continue?

No

Yes

www.abbvie.com
preview.abbviepro.com
www.abbviepro.com
www-p65.abbviepro.com
https://www.abbviemeetings.com/yVQ7xl
https://www.abbviemeetings.com/
https://image.abbviemail.com/lib/fe9813737465047a71/m/1/f0cd3d61-4242-4d97-8c44-f1039c3bb0f0.pdf
https://www.emcpi.com/grp/251
https://www.emcpi.com/grp/252
https://www.emcpi.com/grp/245
https://www.emcpi.com/grp/243
https://www.emcpi.com/grp/239
https://www.emcpi.com/grp/238
https://www.emcpi.com/grp/235
https://www.emcpi.com/grp/234
https://www.emcpi.com/grp/246
https://www.emcpi.com/

Welcome

To direct you to the most appropriate information, please confirm:

I am a UK Healthcare Professional.

This AbbVie website is intended for UK Healthcare Professionals only and contains promotional content.

Confirm

I am a member of the public based in the UK

Continue

Report adverse events (healthcare professionals in the UK)

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.

Adverse events should also be reported to AbbVie at GBPV@abbvie.com

Reporting of side effects (patients and public in the UK)

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at GBPV@abbvie.com

By reporting side effects you can help provide more information on the safety of this medicine.

For medicines with black triangle:

▼ means the medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at GBPV@abbvie.com

UK-ABBV-230223. Date of preparation: June 2023

Matches for {{key}}

{{result.pageTitle}}
{{result.specialization}}

Matches for {{key}}

{{result.pageTitle}}
{{result.specialization}}

No result found for {{key}}